Bristol-Myers Squibb Co 2020 Sustainability Report
The report describes Bristol Myers Squibb's 2020 ESG strategy and progress following the Celgene and MyoKardia acquisitions. It highlights new 2030 and 2040 environmental goals covering renewable electricity, net-neutral GHG emissions and zero waste to landfill. The report maps the company's activities to 10 Sustainable Development Goals and reports in accordance with the GRI Standards Core option, alongside SASB and CDP disclosures.
Company: Bristol-Myers Squibb Co
Sector: Manufacturing
Country: United States
Year: 2020
Type: Sustainability Report
Pages: 82
Back to company
Bristol-Myers Squibb Co
Environmental, Social And Governance Report
The report describes Bristol Myers Squibb's 2020 ESG strategy and progress following the Celgene and MyoKardia acquisitions. It highlights new 2030 and 2040 environmental goals covering renewable electricity, net-neutral GHG emissions and zero waste to landfill. The report maps the company's activities to 10 Sustainable Development Goals and reports in accordance with the GRI Standards Core option, alongside SASB and CDP disclosures.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees